Indo Borax & Chemicals Q4 FY26 Net Profit Rises to ₹1,450 Lakhs; Recommends ₹40 Dividend
Indo Borax & Chemicals reported a Q4 FY26 standalone net profit of ₹1,450.27 lakhs, up from ₹911.11 lakhs year-on-year. Full-year net profit was ₹4,973.97 lakhs. The company recommended a total dividend of ₹40 per share (₹10 final, ₹30 special), subject to shareholder approval.
The increase in profit and the recommended dividend are positive financial indicators. However, the announcement does not involve major strategic shifts, acquisitions, or regulatory changes that would have a high impact.
The company reported significant growth in net profit for both the quarter and the full year, and recommended a substantial dividend, indicating positive financial performance and returns to shareholders.
Indo Borax & Chemicals Limited announced its financial results for the quarter and year ended March 31, 2026. The company reported a standalone net profit of ₹1,450.27 lakhs for the quarter, a significant increase from ₹911.11 lakhs in the same quarter last year. For the full year, the net profit stood at ₹4,973.97 lakhs, up from ₹4,188.20 lakhs in the previous year.
The Board of Directors has recommended a final dividend of ₹10 per equity share and a special dividend of ₹30 per equity share, totaling ₹40 per share. This recommendation is subject to shareholder approval at the upcoming Annual General Meeting.
The company's total income from operations (net) for the quarter was ₹6,748.92 lakhs, and for the year, it was ₹23,017.49 lakhs on a standalone basis. Consolidated figures also showed growth, with a net profit of ₹5,026.98 lakhs for the year.
The results were reviewed by the Audit Committee and approved by the Board of Directors on May 21, 2026. There were no qualifications in the audit report for the year ended March 31, 2026.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.